Nonprofit · EIN 20-1891037
OCULAR IMMUNOLOGY AND UVEITIS FOUNDATION INC
Tax-exempt · WESTON, MA 02493
Financials
| Year ended | Form | Revenue | Expenses | Net income | Total assets | Liabilities | Net assets |
|---|---|---|---|---|---|---|---|
| December 31, 2024 | 990 | $1,565,787 | $706,796 | $858,991 | $3,006,646 | $3,045 | $3,003,601 |
| December 31, 2023 | 990 | $1,638,698 | $704,660 | $934,038 | $2,230,654 | $122,391 | $2,108,263 |
| December 31, 2022 | 990 | $733,623 | $733,858 | -$235 | $1,079,830 | $68,879 | $1,010,951 |
Financial details: 990 for the year ended December 31, 2024
Revenue
- Contributions, gifts and grants
- $1,307,421
- Program service revenue
- $0
- Investment income
- $123,939
- Net gain from sales of assets
- $70,439
- Net income from fundraising events
- $134,427
- Other revenue
- $134,427
Expenses
- Grants and similar amounts paid
- $0
- Salaries, compensation and benefits (total)
- $0
- Professional fundraising fees
- $0
- Accounting fees
- $15,193
- Occupancy
- $39,030
- Travel
- $56,259
- Depreciation
- $6,004
- Program services (functional)
- $447,828
- Management and general (functional)
- $72,995
- Fundraising (functional)
- $185,973
Balance sheet and other
- Total assets, start of year
- $2,230,654
- Total assets, end of year
- $3,006,646
- Total liabilities, end of year
- $3,045
- Net assets, end of year
- $3,003,601
- Land, buildings and equipment
- $7,759
- Publicly traded securities
- $1,605,338
- Net assets without donor restrictions
- $3,003,601
- Gross receipts
- $1,889,961
- Employees
- 0
- Volunteers
- 30
- Year formed
- 2004
- State of legal domicile
- MA
From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.
Officers, directors and key employees
As listed on the 990 for the year ended December 31, 2024, highest compensation first.
| Name | Title | Hours / week | Compensation |
|---|---|---|---|
| DR STEPHEN FOSTER | FOUNDER AND PRESIDENT EMERITUS Trustee or director, Officer | 8 | $0 |
| SCOTT EVANS | TREASURER Trustee or director, Officer | 5 | $0 |
| PETER NETLAND MD | DIRECTOR Trustee or director | 0 | $0 |
| DR DAVID S CHU | PRESIDENT Trustee or director, Officer | 0 | $0 |
| ANDREA PATISTEAS | VICE CHAIR Trustee or director, Officer | 0 | $0 |
| DR ALBERT T VITALE | DIRECTOR Trustee or director | 0 | $0 |
| MICHAEL ACHO | DIRECTOR Trustee or director | 0 | $0 |
| DR STEPHEN ANESI | DIRECTOR Trustee or director | 0 | $0 |
| DR PETER CHANG | DIRECTOR Trustee or director | 0 | $0 |
| CATHERINE POWERS | DIRECTOR Trustee or director | 0 | $0 |
| DR RAJIV SHAH | CLERK Trustee or director, Officer | 0 | $0 |
| LUIS GONZALEZ MD | DIRECTOR Trustee or director | 0 | $0 |
| FRANCES FOSTER | DIRECTOR Trustee or director | 0 | $0 |
990 for the year ended December 31, 2023: 13 people
| Name | Title | Hours / week | Compensation |
|---|---|---|---|
| DR STEPHEN FOSTER | PRESIDENT Trustee or director, Officer | 8 | $0 |
| SCOTT EVANS | DIRECTOR / TREASURER Trustee or director, Officer | 5 | $0 |
| PETER NETLAND MD | DIRECTOR Trustee or director | 0 | $0 |
| DR DAVID S CHU | DIRECTOR Trustee or director | 0 | $0 |
| ANDREA PATISTEAS | VICE CHAIR Trustee or director, Officer | 0 | $0 |
| DR ALBERT T VITALE | DIRECTOR Trustee or director | 0 | $0 |
| MICHAEL ACHO | DIRECTOR Trustee or director | 0 | $0 |
| DR STEPHEN ANESI | DIRECTOR Trustee or director | 0 | $0 |
| DR PETER CHANG | DIRECTOR Trustee or director | 0 | $0 |
| CATHERINE POWERS | DIRECTOR Trustee or director | 0 | $0 |
| DR RAJIV SHAH | CLERK Trustee or director, Officer | 0 | $0 |
| LUIS GONZALEZ MD | DIRECTOR Trustee or director | 0 | $0 |
| SHARON GITELLE | DIRECTOR Trustee or director | 0 | $0 |
990 for the year ended December 31, 2022: 14 people
| Name | Title | Hours / week | Compensation |
|---|---|---|---|
| DR STEPHEN FOSTER | PRESIDENT Trustee or director, Officer | 8 | $0 |
| A RICHARD HERSUM | DIRECTOR / VICE CHAIRMAN Trustee or director, Officer | 0 | $0 |
| SCOTT EVANS | DIRECTOR / TREASURER Trustee or director, Officer | 5 | $0 |
| PETER NETLAND MD | DIRECTOR Trustee or director | 0 | $0 |
| DR DAVID S CHU | DIRECTOR Trustee or director | 0 | $0 |
| ANDREA PATISTEAS | VICE CHAIR Trustee or director, Officer | 0 | $0 |
| DR ALBERT T VITALE | DIRECTOR Trustee or director | 0 | $0 |
| GREG HUGHES | DIRECTOR Trustee or director | 0 | $0 |
| MICHAEL ACHO | DIRECTOR Trustee or director | 0 | $0 |
| DR STEPHEN ANESI | DIRECTOR Trustee or director | 0 | $0 |
| DR PETER CHANG | DIRECTOR Trustee or director | 0 | $0 |
| CATHERINE POWERS | DIRECTOR Trustee or director | 0 | $0 |
| DR RAJIV SHAH | CLERK Trustee or director, Officer | 0 | $0 |
| LUIS GONZALEZ MD | DIRECTOR Trustee or director | 0 | $0 |
Address and contacts
- Address (IRS master file)
- 348 GLEN RD, WESTON, MA 02493-1403
- In care of
- % C STEPHEN FOSTER MD
- Principal officer (990 for 2024)
- SCOTT EVANS, 348 GLEN ROAD, WESTON, MA 02493
- Signed the 990
- SCOTT EVANS, TREASURER
- Phone
- (617) 461-3933
- Website
- WWW.UVEITIS.ORG
- Return prepared by
- TREEFUL DAMASO ANICETO INC
Mission
THE OCULAR IMMUNOLOGY AND UVEITIS FOUNDATION IS DEDICATED TO IMPROVING THE DIAGNOSIS AND TREATMENT AND FINDING THE CAUSES AND CURES OF UVEITIS AND OTHER OCULAR INFLAMMATORY DISEASES, INCREASE AWARENESS OF UVEITIS AMOUNG HEALTH PROFESSIONALS AND THE PUBLIC, AND SUPPORT INDIVIDUALS AND FAMILIES AFFECTED BY THE DISEASE.
Program accomplishments
- VARIOUS RESEARCH STUDIES AND DEVELOPMENT TO PROMOTE AND CARRY OUT SCIENTIFIC AND MEDICAL RESEARCH IN THE FIELD OF DISEASES OF THE EYE.Expenses $123,381
- PHYSICIAN EDUCATION CONFERENCE: A COMPREHENSIVE COVERAGE OF NEW AND EMERGING DEVELOPMENTS IN THE SUBSPECIALTIES OF CORNEA, GLAUCOMA, CATARACT & REFRACTIVE SURGERY, OCULOPLASTICS, UVEITIS AND INFECTIOUS DISEASE. THE FACULTY CONSISTED OF NINETEEN OPHTHALMOLOGISTS. PHYSICIANS FROM ALL OVER NEW ENGLAND ATTENDED THE CONFERENCE.Expenses $267,600 · revenue $40,000
- SUPPORT GROUP PROGRAMS, CONSISTS GENERALLY OF GROUP SPEAKERS, EDUCATIONAL AND SUPPORT RESOURCES.Expenses $56,847
What it must file and when
IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.
| Tax year | Year ended | Due | IRS public records |
|---|---|---|---|
| 2025 | December 31, 2025 | May 15, 2026 | Not on file |
| 2024 | December 31, 2024 | May 15, 2025 | 990 on file |
| 2023 | December 31, 2023 | May 15, 2024 | 990 on file |
IRS record
- EIN
- 20-1891037
- Tax-exempt status
- 501(c)(3): Charitable, religious, educational or scientific organization
- Foundation status
- Publicly supported organization (170(b)(1)(A)(vi))
- Donations deductible (Pub 78)
- Public charity, 50% deduction limit
- Exempt since
- 2006
- Accounting year ends
- December
- Files
- Form 990 or 990-EZ
- Category (NTEE)
- Medical research (H41)
- Assets (IRS master file)
- $3,006,646
- Income (IRS master file)
- $1,889,961
Filing history
| Form | Year ended | Revenue | Expenses | Assets | Return |
|---|---|---|---|---|---|
| 990 | December 2024 | $1,565,787 | $706,796 | $3,006,646 | XML |
| 990 | December 2023 | $1,638,698 | $704,660 | $2,230,654 | XML |
| 990 | December 2022 | $733,623 | $733,858 | $1,079,830 | XML |
| 990 | December 2021 | – | – | – | IRS |
| 990 | December 2020 | – | – | – | IRS |
| 990 | December 2018 | – | – | – | IRS |
990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 20-1891037).
Questions about OCULAR IMMUNOLOGY AND UVEITIS FOUNDATION INC
- What is the EIN of OCULAR IMMUNOLOGY AND UVEITIS FOUNDATION INC?
- The employer identification number (EIN) of OCULAR IMMUNOLOGY AND UVEITIS FOUNDATION INC is 20-1891037.
- Is OCULAR IMMUNOLOGY AND UVEITIS FOUNDATION INC tax-exempt?
- Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 2006.
- Are donations to OCULAR IMMUNOLOGY AND UVEITIS FOUNDATION INC tax-deductible?
- Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
- Which annual return does OCULAR IMMUNOLOGY AND UVEITIS FOUNDATION INC file?
- Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
- When is the next return of OCULAR IMMUNOLOGY AND UVEITIS FOUNDATION INC due?
- The return for tax year 2025 (the year ending December 31, 2025) is due May 15, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
- When did OCULAR IMMUNOLOGY AND UVEITIS FOUNDATION INC last file with the IRS?
- The latest return in the IRS public files is the 990 for the year ended December 2024.
- Who is the principal officer of OCULAR IMMUNOLOGY AND UVEITIS FOUNDATION INC?
- The 990 for the year ended December 31, 2024 names SCOTT EVANS.
- Who are the officers and directors of OCULAR IMMUNOLOGY AND UVEITIS FOUNDATION INC?
- The 990 for the year ended December 31, 2024 lists 13 people; 0 received compensation from the organization.
- How much revenue does OCULAR IMMUNOLOGY AND UVEITIS FOUNDATION INC have?
- On its 990 for the year ended December 31, 2024 it reported revenue of $1,565,787, expenses of $706,796 and total assets of $3,006,646 at year end.
Other nonprofits in WESTON
- MIND FIRST FOUNDATION EIN 46-1357012 · last filed 990 for 2024
- DIANAS FIBROID FOUNDATION INC EIN 85-0872157 · last filed 990-PF for 2025
- STRIKE OUT CANCER INC EIN 06-1644356 · last filed 990-N for 2024
- BOSTON COGNITIVE SOLUTIONS INC EIN 82-1685536 · last filed 990-N for 2023
- GLOBAL NEUROSCIENCE INITIATIVE FOUNDATION EIN 20-1404366 · last filed 990-N for 2025
- REGIS COLLEGE EIN 04-2104451 · last filed 990 for 2025
- RIVERS SCHOOL CORPORATION EIN 04-2104457 · last filed 990 for 2025
- MEADOWBROOK SCHOOL OF WESTON INCORPORATED EIN 04-2104720 · last filed 990 for 2025